| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Transplantation | 15 | 2023 | 854 | 0.640 |
Why?
|
| Cardiomyopathy, Dilated | 8 | 2022 | 214 | 0.630 |
Why?
|
| Cardiomyopathies | 7 | 2022 | 481 | 0.590 |
Why?
|
| Heart Ventricles | 9 | 2023 | 767 | 0.580 |
Why?
|
| Myocardium | 16 | 2013 | 982 | 0.440 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2013 | 87 | 0.410 |
Why?
|
| Graft Rejection | 9 | 2023 | 582 | 0.410 |
Why?
|
| Biopsy | 11 | 2023 | 1239 | 0.380 |
Why?
|
| Choristoma | 1 | 2011 | 49 | 0.380 |
Why?
|
| Stomach Diseases | 1 | 2011 | 56 | 0.370 |
Why?
|
| Cysts | 1 | 2011 | 100 | 0.360 |
Why?
|
| Pancreatectomy | 1 | 2011 | 135 | 0.360 |
Why?
|
| Pancreas | 1 | 2011 | 210 | 0.360 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2013 | 253 | 0.340 |
Why?
|
| Persistent Fetal Circulation Syndrome | 3 | 2016 | 89 | 0.340 |
Why?
|
| Heart Aneurysm | 2 | 2023 | 38 | 0.290 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2011 | 366 | 0.250 |
Why?
|
| Lung | 4 | 2024 | 1468 | 0.240 |
Why?
|
| Myocarditis | 6 | 2010 | 119 | 0.240 |
Why?
|
| Infant | 32 | 2024 | 12286 | 0.240 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 2024 | 30 | 0.220 |
Why?
|
| Heart | 8 | 2022 | 726 | 0.220 |
Why?
|
| T-Box Domain Proteins | 1 | 2024 | 122 | 0.220 |
Why?
|
| Diverticulum | 1 | 2023 | 28 | 0.220 |
Why?
|
| Calcinosis | 1 | 2024 | 167 | 0.210 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2003 | 107 | 0.210 |
Why?
|
| Coronary Thrombosis | 2 | 2000 | 33 | 0.200 |
Why?
|
| Forkhead Transcription Factors | 2 | 2016 | 370 | 0.200 |
Why?
|
| Nervous System Malformations | 1 | 2024 | 127 | 0.200 |
Why?
|
| Humans | 76 | 2024 | 122998 | 0.200 |
Why?
|
| Mitochondrial Diseases | 1 | 2024 | 135 | 0.200 |
Why?
|
| Fetal Death | 2 | 2019 | 113 | 0.200 |
Why?
|
| Aneurysm, False | 1 | 2023 | 101 | 0.200 |
Why?
|
| Infant, Newborn | 23 | 2022 | 8070 | 0.190 |
Why?
|
| Tachycardia, Ventricular | 2 | 2006 | 196 | 0.190 |
Why?
|
| Mutation | 6 | 2024 | 5773 | 0.190 |
Why?
|
| Atrioventricular Node | 2 | 1998 | 16 | 0.180 |
Why?
|
| Aortic Valve | 3 | 2020 | 428 | 0.180 |
Why?
|
| Coronary Vessel Anomalies | 3 | 2012 | 274 | 0.180 |
Why?
|
| Heart Valve Diseases | 3 | 2011 | 167 | 0.170 |
Why?
|
| Diagnosis, Differential | 6 | 2024 | 1870 | 0.170 |
Why?
|
| Child, Preschool | 26 | 2011 | 13819 | 0.170 |
Why?
|
| Extracellular Matrix | 2 | 2011 | 231 | 0.170 |
Why?
|
| Siderosis | 1 | 2019 | 2 | 0.160 |
Why?
|
| Complement Membrane Attack Complex | 1 | 2019 | 7 | 0.160 |
Why?
|
| Catheterization | 3 | 2016 | 234 | 0.160 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2020 | 138 | 0.160 |
Why?
|
| Male | 43 | 2024 | 59901 | 0.160 |
Why?
|
| Liver Failure | 1 | 2019 | 89 | 0.150 |
Why?
|
| Endocardial Fibroelastosis | 3 | 2010 | 11 | 0.150 |
Why?
|
| Acute Coronary Syndrome | 1 | 2020 | 201 | 0.150 |
Why?
|
| Parvovirus B19, Human | 3 | 2010 | 30 | 0.140 |
Why?
|
| Immunity, Humoral | 1 | 2018 | 69 | 0.140 |
Why?
|
| Female | 44 | 2024 | 65310 | 0.140 |
Why?
|
| Parvoviridae Infections | 3 | 2010 | 36 | 0.140 |
Why?
|
| Tachycardia, Supraventricular | 1 | 1998 | 107 | 0.140 |
Why?
|
| Heart Diseases | 2 | 2013 | 483 | 0.140 |
Why?
|
| Echocardiography | 8 | 2012 | 1069 | 0.140 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2019 | 171 | 0.140 |
Why?
|
| Hypercholesterolemia | 1 | 1999 | 226 | 0.140 |
Why?
|
| Child | 32 | 2023 | 24144 | 0.140 |
Why?
|
| HIV Infections | 3 | 2004 | 1864 | 0.140 |
Why?
|
| Iron | 1 | 2019 | 261 | 0.130 |
Why?
|
| Genome, Viral | 3 | 2010 | 171 | 0.130 |
Why?
|
| Pneumatosis Cystoides Intestinalis | 1 | 2016 | 9 | 0.130 |
Why?
|
| Sequence Deletion | 2 | 2016 | 527 | 0.130 |
Why?
|
| I-kappa B Kinase | 1 | 2016 | 60 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2016 | 150 | 0.130 |
Why?
|
| Common Variable Immunodeficiency | 1 | 2016 | 26 | 0.130 |
Why?
|
| Catheter Ablation | 1 | 1998 | 233 | 0.130 |
Why?
|
| Tachycardia | 4 | 1992 | 68 | 0.130 |
Why?
|
| Cytoskeletal Proteins | 2 | 2022 | 270 | 0.130 |
Why?
|
| Immunization, Passive | 1 | 2016 | 118 | 0.130 |
Why?
|
| Arrhythmias, Cardiac | 4 | 2022 | 457 | 0.130 |
Why?
|
| Pulmonary Alveoli | 1 | 2016 | 132 | 0.120 |
Why?
|
| Enteritis | 1 | 2016 | 54 | 0.120 |
Why?
|
| Ventricular Dysfunction, Right | 2 | 2000 | 78 | 0.120 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2016 | 293 | 0.120 |
Why?
|
| Hemangioma, Capillary | 1 | 2015 | 17 | 0.120 |
Why?
|
| Abnormalities, Multiple | 2 | 2012 | 964 | 0.120 |
Why?
|
| Muscle Proteins | 2 | 2022 | 417 | 0.120 |
Why?
|
| Myocytes, Cardiac | 6 | 2012 | 617 | 0.120 |
Why?
|
| Liver | 3 | 2019 | 1727 | 0.120 |
Why?
|
| Pulmonary Artery | 3 | 2009 | 439 | 0.110 |
Why?
|
| RNA, Long Noncoding | 1 | 2016 | 210 | 0.110 |
Why?
|
| Heart Failure | 3 | 2022 | 2123 | 0.110 |
Why?
|
| Camellia sinensis | 1 | 2013 | 3 | 0.110 |
Why?
|
| Mutation, Missense | 3 | 2024 | 845 | 0.110 |
Why?
|
| Respiratory Insufficiency | 1 | 2016 | 234 | 0.110 |
Why?
|
| Anti-Obesity Agents | 1 | 2013 | 42 | 0.110 |
Why?
|
| Adolescent | 23 | 2016 | 19030 | 0.110 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2011 | 171 | 0.110 |
Why?
|
| Aortic Valve Stenosis | 4 | 2011 | 325 | 0.110 |
Why?
|
| Fatal Outcome | 5 | 2015 | 357 | 0.100 |
Why?
|
| Caliciviridae Infections | 1 | 2016 | 319 | 0.100 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2013 | 137 | 0.100 |
Why?
|
| Fetal Therapies | 1 | 2013 | 72 | 0.100 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2013 | 105 | 0.100 |
Why?
|
| RNA-Binding Proteins | 2 | 2007 | 573 | 0.100 |
Why?
|
| Cardiomyopathy, Hypertrophic, Familial | 1 | 2012 | 4 | 0.100 |
Why?
|
| Liver Failure, Acute | 1 | 2013 | 87 | 0.100 |
Why?
|
| Ventricular Function, Right | 1 | 2013 | 112 | 0.100 |
Why?
|
| Vascular Fistula | 1 | 2012 | 30 | 0.100 |
Why?
|
| Mice, Transgenic | 8 | 2012 | 2391 | 0.100 |
Why?
|
| Plant Extracts | 1 | 2013 | 120 | 0.100 |
Why?
|
| Telomere | 1 | 2013 | 208 | 0.100 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 1999 | 714 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 7 | 2010 | 1586 | 0.100 |
Why?
|
| Radiography, Abdominal | 1 | 2011 | 47 | 0.100 |
Why?
|
| Follow-Up Studies | 8 | 2011 | 5031 | 0.090 |
Why?
|
| Carrier Proteins | 2 | 2010 | 1021 | 0.090 |
Why?
|
| ADAM Proteins | 1 | 2011 | 79 | 0.090 |
Why?
|
| Mucinoses | 1 | 2010 | 2 | 0.090 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 1 | 2011 | 54 | 0.090 |
Why?
|
| Chromosome Deletion | 1 | 2013 | 638 | 0.090 |
Why?
|
| Heart Defects, Congenital | 4 | 2011 | 1801 | 0.090 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2015 | 383 | 0.090 |
Why?
|
| Thromboxane A2 | 2 | 2000 | 19 | 0.090 |
Why?
|
| Coronary Artery Disease | 3 | 2012 | 743 | 0.090 |
Why?
|
| Heart Neoplasms | 3 | 1987 | 101 | 0.090 |
Why?
|
| Genetic Association Studies | 1 | 2013 | 760 | 0.090 |
Why?
|
| Hamartoma | 2 | 1987 | 51 | 0.080 |
Why?
|
| Time Factors | 7 | 2013 | 6198 | 0.080 |
Why?
|
| Myocardial Stunning | 1 | 2009 | 21 | 0.080 |
Why?
|
| Codon, Nonsense | 2 | 2012 | 131 | 0.080 |
Why?
|
| Heart Septal Defects, Ventricular | 2 | 2008 | 133 | 0.080 |
Why?
|
| Waiting Lists | 1 | 2011 | 224 | 0.080 |
Why?
|
| Heart Septum | 2 | 2000 | 56 | 0.080 |
Why?
|
| Pulmonary Valve | 1 | 2010 | 96 | 0.080 |
Why?
|
| Nontuberculous Mycobacteria | 1 | 2009 | 35 | 0.080 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2016 | 627 | 0.080 |
Why?
|
| Skin Diseases | 1 | 2010 | 122 | 0.080 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2009 | 146 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2012 | 2041 | 0.080 |
Why?
|
| Developmental Disabilities | 1 | 2013 | 695 | 0.080 |
Why?
|
| Aorta, Thoracic | 1 | 2013 | 516 | 0.080 |
Why?
|
| Mycobacterium Infections, Nontuberculous | 1 | 2009 | 59 | 0.080 |
Why?
|
| Biliary Atresia | 1 | 2011 | 186 | 0.080 |
Why?
|
| Subclavian Artery | 2 | 2001 | 71 | 0.080 |
Why?
|
| HIV-1 | 2 | 2004 | 465 | 0.080 |
Why?
|
| Zidovudine | 1 | 2007 | 22 | 0.070 |
Why?
|
| Fas Ligand Protein | 1 | 2007 | 33 | 0.070 |
Why?
|
| Actin Cytoskeleton | 2 | 2022 | 44 | 0.070 |
Why?
|
| Adenoviridae | 3 | 2010 | 605 | 0.070 |
Why?
|
| Cholestasis | 1 | 2008 | 148 | 0.070 |
Why?
|
| Desmosomes | 1 | 2006 | 7 | 0.070 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2007 | 125 | 0.070 |
Why?
|
| Desmoplakins | 1 | 2006 | 11 | 0.070 |
Why?
|
| Transposition of Great Vessels | 2 | 2001 | 132 | 0.070 |
Why?
|
| Alternative Splicing | 2 | 2007 | 346 | 0.070 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 1 | 2006 | 17 | 0.070 |
Why?
|
| Abscess | 2 | 2004 | 138 | 0.070 |
Why?
|
| Catecholamines | 1 | 2006 | 56 | 0.070 |
Why?
|
| Retrospective Studies | 10 | 2023 | 15931 | 0.070 |
Why?
|
| Andersen Syndrome | 1 | 2006 | 6 | 0.070 |
Why?
|
| Ultrasonography | 4 | 2015 | 945 | 0.070 |
Why?
|
| Adult | 16 | 2023 | 28980 | 0.070 |
Why?
|
| Cystic Fibrosis | 1 | 2009 | 257 | 0.070 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2006 | 34 | 0.070 |
Why?
|
| Intellectual Disability | 1 | 2013 | 1043 | 0.070 |
Why?
|
| Myotonic Dystrophy | 1 | 2007 | 145 | 0.070 |
Why?
|
| Hodgkin Disease | 1 | 2008 | 293 | 0.060 |
Why?
|
| Aortic Stenosis, Supravalvular | 1 | 2006 | 19 | 0.060 |
Why?
|
| Glycogen Storage Disease Type IIb | 1 | 2005 | 5 | 0.060 |
Why?
|
| Endocardial Cushion Defects | 1 | 2005 | 7 | 0.060 |
Why?
|
| Neuroblastoma | 1 | 2010 | 509 | 0.060 |
Why?
|
| Risk Factors | 9 | 2018 | 9974 | 0.060 |
Why?
|
| Cardiac Catheterization | 3 | 2023 | 634 | 0.060 |
Why?
|
| Lung Neoplasms | 1 | 2015 | 1581 | 0.060 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 1 | 2005 | 28 | 0.060 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2006 | 84 | 0.060 |
Why?
|
| Ischium | 1 | 2024 | 6 | 0.060 |
Why?
|
| Mice | 9 | 2022 | 17469 | 0.060 |
Why?
|
| Lower Extremity Deformities, Congenital | 1 | 2024 | 13 | 0.060 |
Why?
|
| Lung Transplantation | 1 | 2009 | 316 | 0.060 |
Why?
|
| Hip | 1 | 2024 | 20 | 0.060 |
Why?
|
| Laryngectomy | 1 | 2004 | 25 | 0.060 |
Why?
|
| Laryngeal Diseases | 1 | 2004 | 31 | 0.060 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 2837 | 0.060 |
Why?
|
| Aspergillosis | 1 | 2004 | 43 | 0.060 |
Why?
|
| Patella | 1 | 2024 | 29 | 0.060 |
Why?
|
| Death, Sudden, Cardiac | 2 | 2000 | 246 | 0.060 |
Why?
|
| Anti-HIV Agents | 1 | 2007 | 305 | 0.060 |
Why?
|
| Cardiomegaly | 1 | 2005 | 133 | 0.060 |
Why?
|
| Liver Cirrhosis | 1 | 2011 | 819 | 0.060 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2008 | 906 | 0.060 |
Why?
|
| Bone Diseases, Developmental | 1 | 2024 | 62 | 0.060 |
Why?
|
| RNA, Messenger | 2 | 2008 | 2820 | 0.060 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2006 | 232 | 0.060 |
Why?
|
| Electrocardiography | 5 | 2012 | 961 | 0.060 |
Why?
|
| Amino Acyl-tRNA Synthetases | 1 | 2024 | 27 | 0.060 |
Why?
|
| Anti-Arrhythmia Agents | 3 | 2022 | 218 | 0.060 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2005 | 152 | 0.060 |
Why?
|
| Aorta | 2 | 2020 | 540 | 0.060 |
Why?
|
| Endophthalmitis | 1 | 2004 | 76 | 0.060 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 2004 | 65 | 0.060 |
Why?
|
| Prednisone | 2 | 2008 | 273 | 0.060 |
Why?
|
| Failure to Thrive | 1 | 2004 | 90 | 0.060 |
Why?
|
| Treatment Outcome | 6 | 2016 | 12087 | 0.050 |
Why?
|
| Endocardium | 2 | 2001 | 49 | 0.050 |
Why?
|
| Adenovirus Infections, Human | 1 | 2003 | 49 | 0.050 |
Why?
|
| Endocarditis, Bacterial | 1 | 2004 | 129 | 0.050 |
Why?
|
| Immunosuppressive Agents | 4 | 2004 | 645 | 0.050 |
Why?
|
| Liver Transplantation | 1 | 2011 | 1008 | 0.050 |
Why?
|
| Animals | 13 | 2022 | 33693 | 0.050 |
Why?
|
| Ductus Arteriosus, Patent | 2 | 2001 | 141 | 0.050 |
Why?
|
| Pregnancy | 4 | 2023 | 7115 | 0.050 |
Why?
|
| Immunocompromised Host | 1 | 2004 | 300 | 0.050 |
Why?
|
| Coronary Disease | 3 | 2010 | 638 | 0.050 |
Why?
|
| Sarcomeres | 1 | 2022 | 30 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2010 | 3090 | 0.050 |
Why?
|
| Cytokines | 1 | 2008 | 1280 | 0.050 |
Why?
|
| Organ Size | 1 | 2003 | 412 | 0.050 |
Why?
|
| Environmental Exposure | 1 | 2004 | 218 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2008 | 1230 | 0.050 |
Why?
|
| Subclavian Steal Syndrome | 1 | 2001 | 7 | 0.050 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2003 | 237 | 0.050 |
Why?
|
| Ductus Arteriosus | 1 | 2001 | 64 | 0.050 |
Why?
|
| Aneurysm | 1 | 2001 | 88 | 0.050 |
Why?
|
| Aspirin | 2 | 2000 | 224 | 0.050 |
Why?
|
| Thromboxane B2 | 1 | 2000 | 20 | 0.050 |
Why?
|
| Dinoprost | 1 | 2000 | 28 | 0.050 |
Why?
|
| Cardiomyopathy, Restrictive | 1 | 2000 | 21 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2019 | 1684 | 0.040 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2000 | 88 | 0.040 |
Why?
|
| DNA, Viral | 3 | 2010 | 477 | 0.040 |
Why?
|
| Virus Diseases | 3 | 2003 | 280 | 0.040 |
Why?
|
| Liver Glycogen | 1 | 2000 | 22 | 0.040 |
Why?
|
| Arteriosclerosis | 1 | 2000 | 138 | 0.040 |
Why?
|
| Epoprostenol | 1 | 2000 | 67 | 0.040 |
Why?
|
| Syndrome | 2 | 2016 | 1113 | 0.040 |
Why?
|
| Isoenzymes | 1 | 2000 | 223 | 0.040 |
Why?
|
| Enterovirus | 3 | 2010 | 48 | 0.040 |
Why?
|
| Blood Coagulation Factors | 1 | 1999 | 34 | 0.040 |
Why?
|
| Shock, Cardiogenic | 1 | 2000 | 189 | 0.040 |
Why?
|
| Azathioprine | 1 | 1998 | 54 | 0.040 |
Why?
|
| Atherosclerosis | 1 | 2006 | 828 | 0.040 |
Why?
|
| Stillbirth | 1 | 2019 | 79 | 0.040 |
Why?
|
| Perinatal Care | 1 | 2019 | 67 | 0.040 |
Why?
|
| Age Factors | 4 | 2013 | 2801 | 0.040 |
Why?
|
| Survival Rate | 1 | 2003 | 1993 | 0.040 |
Why?
|
| Prospective Studies | 3 | 2008 | 6023 | 0.040 |
Why?
|
| Cyclosporine | 1 | 1998 | 146 | 0.040 |
Why?
|
| Rats | 3 | 2012 | 3629 | 0.040 |
Why?
|
| Molecular Sequence Data | 4 | 2013 | 3871 | 0.040 |
Why?
|
| Cholesterol, HDL | 1 | 1999 | 348 | 0.040 |
Why?
|
| Acute Disease | 2 | 2018 | 1089 | 0.040 |
Why?
|
| Mumps virus | 1 | 1997 | 4 | 0.040 |
Why?
|
| Mumps | 1 | 1997 | 11 | 0.040 |
Why?
|
| YY1 Transcription Factor | 1 | 2016 | 12 | 0.030 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 1999 | 256 | 0.030 |
Why?
|
| GATA3 Transcription Factor | 1 | 2016 | 39 | 0.030 |
Why?
|
| Esophageal Fistula | 1 | 1996 | 14 | 0.030 |
Why?
|
| Postoperative Care | 1 | 1998 | 292 | 0.030 |
Why?
|
| Fistula | 1 | 1996 | 50 | 0.030 |
Why?
|
| Transplantation, Homologous | 1 | 2018 | 657 | 0.030 |
Why?
|
| Disease Progression | 3 | 2008 | 2027 | 0.030 |
Why?
|
| Genomic Imprinting | 1 | 2016 | 123 | 0.030 |
Why?
|
| Phenotype | 3 | 2012 | 4221 | 0.030 |
Why?
|
| Heart Rate | 1 | 1998 | 585 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2000 | 1113 | 0.030 |
Why?
|
| Opportunistic Infections | 1 | 1996 | 79 | 0.030 |
Why?
|
| CpG Islands | 1 | 2016 | 321 | 0.030 |
Why?
|
| Cholesterol, LDL | 1 | 1999 | 556 | 0.030 |
Why?
|
| Raynaud Disease | 1 | 1995 | 4 | 0.030 |
Why?
|
| Duodenum | 1 | 2016 | 99 | 0.030 |
Why?
|
| Lymphoproliferative Disorders | 1 | 1997 | 224 | 0.030 |
Why?
|
| Submandibular Gland Diseases | 1 | 1994 | 1 | 0.030 |
Why?
|
| Nuclear Family | 1 | 1995 | 50 | 0.030 |
Why?
|
| Antiphospholipid Syndrome | 1 | 1995 | 25 | 0.030 |
Why?
|
| Lymphadenitis | 1 | 1994 | 26 | 0.030 |
Why?
|
| Salmonella Infections | 1 | 1994 | 31 | 0.030 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2016 | 574 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2012 | 3259 | 0.030 |
Why?
|
| Young Adult | 2 | 2023 | 8840 | 0.030 |
Why?
|
| Granuloma | 1 | 1994 | 67 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 2 | 2016 | 1760 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 1999 | 1067 | 0.030 |
Why?
|
| DNA Mutational Analysis | 2 | 2006 | 793 | 0.030 |
Why?
|
| Coronary Vessels | 2 | 1995 | 525 | 0.030 |
Why?
|
| Cell Nucleus | 2 | 2007 | 674 | 0.030 |
Why?
|
| Cytomegalovirus Infections | 1 | 1996 | 217 | 0.030 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2013 | 35 | 0.030 |
Why?
|
| Binding Sites | 1 | 2016 | 1292 | 0.030 |
Why?
|
| Plants, Medicinal | 1 | 2013 | 23 | 0.030 |
Why?
|
| Chromosome Breakpoints | 1 | 2013 | 80 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2013 | 59 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2013 | 2105 | 0.030 |
Why?
|
| Equipment Design | 2 | 1993 | 599 | 0.030 |
Why?
|
| Phytotherapy | 1 | 2013 | 50 | 0.030 |
Why?
|
| Gene Order | 1 | 2013 | 78 | 0.030 |
Why?
|
| Estrogen Receptor alpha | 1 | 2016 | 449 | 0.030 |
Why?
|
| Incidence | 3 | 2010 | 3047 | 0.030 |
Why?
|
| Risk Assessment | 2 | 2013 | 3325 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2013 | 231 | 0.030 |
Why?
|
| Electrocoagulation | 1 | 1992 | 37 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 2013 | 212 | 0.030 |
Why?
|
| Rats, Mutant Strains | 1 | 2012 | 14 | 0.030 |
Why?
|
| Brain | 1 | 2024 | 2943 | 0.030 |
Why?
|
| Cicatrix | 1 | 1993 | 125 | 0.020 |
Why?
|
| Infant Mortality | 1 | 2013 | 175 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2012 | 119 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2013 | 757 | 0.020 |
Why?
|
| Animals, Newborn | 2 | 2012 | 988 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2013 | 623 | 0.020 |
Why?
|
| Vascular Diseases | 2 | 1996 | 162 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2012 | 112 | 0.020 |
Why?
|
| Glomerular Basement Membrane | 1 | 2011 | 9 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2013 | 441 | 0.020 |
Why?
|
| Antibodies, Antiphospholipid | 1 | 2011 | 19 | 0.020 |
Why?
|
| Glycosaminoglycans | 1 | 2011 | 33 | 0.020 |
Why?
|
| Atrial Fibrillation | 1 | 1998 | 623 | 0.020 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2005 | 1101 | 0.020 |
Why?
|
| Proteoglycans | 1 | 2011 | 93 | 0.020 |
Why?
|
| Elastic Tissue | 1 | 2010 | 19 | 0.020 |
Why?
|
| LIM Domain Proteins | 1 | 2010 | 59 | 0.020 |
Why?
|
| ADAMTS13 Protein | 1 | 2011 | 62 | 0.020 |
Why?
|
| Glomerulonephritis | 1 | 2011 | 73 | 0.020 |
Why?
|
| Prenatal Diagnosis | 1 | 2015 | 580 | 0.020 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2010 | 35 | 0.020 |
Why?
|
| Flurandrenolone | 1 | 2010 | 1 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2013 | 471 | 0.020 |
Why?
|
| Coxsackievirus Infections | 1 | 2010 | 9 | 0.020 |
Why?
|
| Betamethasone | 1 | 2010 | 13 | 0.020 |
Why?
|
| Ventricular Remodeling | 1 | 2011 | 175 | 0.020 |
Why?
|
| Sepsis | 1 | 2015 | 478 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2013 | 1083 | 0.020 |
Why?
|
| Apoptosis | 2 | 2007 | 1783 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2012 | 417 | 0.020 |
Why?
|
| Hypertension, Pulmonary | 1 | 2015 | 431 | 0.020 |
Why?
|
| Myocardial Contraction | 1 | 2011 | 261 | 0.020 |
Why?
|
| Autoimmunity | 1 | 2011 | 172 | 0.020 |
Why?
|
| Adenoviridae Infections | 1 | 2010 | 70 | 0.020 |
Why?
|
| Tretinoin | 1 | 2010 | 116 | 0.020 |
Why?
|
| Hyaluronic Acid | 1 | 2010 | 96 | 0.020 |
Why?
|
| Collagen | 1 | 2010 | 312 | 0.020 |
Why?
|
| Mechlorethamine | 1 | 2008 | 8 | 0.020 |
Why?
|
| Procarbazine | 1 | 2008 | 13 | 0.020 |
Why?
|
| Electrophysiology | 2 | 2006 | 268 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 2010 | 262 | 0.020 |
Why?
|
| Vinblastine | 1 | 2008 | 46 | 0.020 |
Why?
|
| Body Weight | 1 | 2013 | 999 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2012 | 1211 | 0.020 |
Why?
|
| Patient Safety | 1 | 2013 | 390 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2013 | 2698 | 0.020 |
Why?
|
| Sputum | 1 | 2009 | 111 | 0.020 |
Why?
|
| Bleomycin | 1 | 2008 | 150 | 0.020 |
Why?
|
| Radiotherapy Dosage | 1 | 2008 | 185 | 0.020 |
Why?
|
| Pedigree | 1 | 2012 | 1582 | 0.020 |
Why?
|
| Graft Survival | 1 | 2010 | 524 | 0.020 |
Why?
|
| Remission Induction | 1 | 2008 | 300 | 0.020 |
Why?
|
| Vincristine | 1 | 2008 | 195 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2011 | 500 | 0.020 |
Why?
|
| Base Sequence | 3 | 1999 | 3093 | 0.020 |
Why?
|
| Interleukin-18 | 1 | 2008 | 60 | 0.020 |
Why?
|
| Myotonin-Protein Kinase | 1 | 2007 | 40 | 0.020 |
Why?
|
| Lymphocytes | 1 | 1989 | 403 | 0.020 |
Why?
|
| Protein Binding | 1 | 2012 | 1741 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2011 | 482 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2007 | 123 | 0.020 |
Why?
|
| CELF1 Protein | 1 | 2007 | 48 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 1995 | 997 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2008 | 160 | 0.020 |
Why?
|
| Doxorubicin | 1 | 2008 | 300 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2010 | 1005 | 0.020 |
Why?
|
| Preoperative Care | 2 | 1992 | 350 | 0.020 |
Why?
|
| Stents | 1 | 1993 | 866 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2012 | 811 | 0.020 |
Why?
|
| Risk | 1 | 2009 | 750 | 0.020 |
Why?
|
| Troponin I | 1 | 2007 | 98 | 0.020 |
Why?
|
| HIV Seropositivity | 1 | 2007 | 116 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 1987 | 391 | 0.020 |
Why?
|
| Intercellular Junctions | 1 | 2006 | 25 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2010 | 850 | 0.020 |
Why?
|
| Xenopus | 1 | 2006 | 107 | 0.020 |
Why?
|
| Heart Conduction System | 1 | 1987 | 145 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2008 | 393 | 0.020 |
Why?
|
| Caffeine | 1 | 2006 | 71 | 0.020 |
Why?
|
| Lysosomal-Associated Membrane Protein 2 | 1 | 2005 | 9 | 0.020 |
Why?
|
| Papillary Muscles | 1 | 2005 | 19 | 0.020 |
Why?
|
| Postoperative Complications | 2 | 1998 | 3005 | 0.020 |
Why?
|
| Cell Communication | 1 | 2006 | 165 | 0.020 |
Why?
|
| CELF Proteins | 1 | 2005 | 13 | 0.020 |
Why?
|
| Length of Stay | 1 | 2011 | 1283 | 0.020 |
Why?
|
| Central Nervous System Stimulants | 1 | 2006 | 125 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2008 | 511 | 0.020 |
Why?
|
| Vasoconstrictor Agents | 1 | 2006 | 137 | 0.020 |
Why?
|
| Prognosis | 2 | 2009 | 4490 | 0.020 |
Why?
|
| Epinephrine | 1 | 2006 | 174 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2012 | 1267 | 0.020 |
Why?
|
| Cell Line | 1 | 2010 | 2779 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2007 | 1102 | 0.020 |
Why?
|
| Lung Diseases | 1 | 2009 | 385 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2008 | 1240 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2008 | 670 | 0.020 |
Why?
|
| Recurrence | 1 | 2009 | 1419 | 0.020 |
Why?
|
| Penetrance | 1 | 2005 | 103 | 0.020 |
Why?
|
| Wolff-Parkinson-White Syndrome | 1 | 2005 | 73 | 0.020 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2004 | 24 | 0.020 |
Why?
|
| Whole-Body Irradiation | 1 | 2004 | 65 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2005 | 462 | 0.010 |
Why?
|
| Muscular Diseases | 1 | 2005 | 102 | 0.010 |
Why?
|
| Angiography | 1 | 2005 | 215 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2006 | 452 | 0.010 |
Why?
|
| Prevalence | 1 | 2010 | 2394 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2005 | 714 | 0.010 |
Why?
|
| NADPH Oxidases | 1 | 2004 | 115 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2006 | 353 | 0.010 |
Why?
|
| Blood Vessel Prosthesis | 1 | 1988 | 524 | 0.010 |
Why?
|
| Drug Therapy, Combination | 2 | 1998 | 1148 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 3510 | 0.010 |
Why?
|
| Heart-Assist Devices | 1 | 1992 | 1022 | 0.010 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2004 | 241 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2005 | 697 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2012 | 4342 | 0.010 |
Why?
|
| Texas | 1 | 2011 | 3542 | 0.010 |
Why?
|
| Autopsy | 2 | 1994 | 110 | 0.010 |
Why?
|
| Neoplasms | 1 | 1997 | 2750 | 0.010 |
Why?
|
| Antifungal Agents | 1 | 2004 | 293 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2004 | 399 | 0.010 |
Why?
|
| Aortic Diseases | 1 | 2004 | 197 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 2004 | 576 | 0.010 |
Why?
|
| Sex Factors | 1 | 2005 | 1254 | 0.010 |
Why?
|
| Necrosis | 1 | 2001 | 205 | 0.010 |
Why?
|
| 6-Ketoprostaglandin F1 alpha | 1 | 2000 | 10 | 0.010 |
Why?
|
| F2-Isoprostanes | 1 | 2000 | 23 | 0.010 |
Why?
|
| Ventricular Pressure | 1 | 2000 | 43 | 0.010 |
Why?
|
| Cyclooxygenase 1 | 1 | 2000 | 40 | 0.010 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2000 | 63 | 0.010 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2000 | 60 | 0.010 |
Why?
|
| Dilatation, Pathologic | 1 | 2000 | 93 | 0.010 |
Why?
|
| Ketones | 1 | 2000 | 24 | 0.010 |
Why?
|
| Vascular Surgical Procedures | 1 | 2005 | 564 | 0.010 |
Why?
|
| Dietary Sucrose | 1 | 2000 | 41 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2000 | 158 | 0.010 |
Why?
|
| Dogs | 2 | 1993 | 763 | 0.010 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2000 | 136 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2006 | 3283 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2000 | 330 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2005 | 939 | 0.010 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2000 | 239 | 0.010 |
Why?
|
| Animals, Genetically Modified | 1 | 2000 | 316 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2000 | 359 | 0.010 |
Why?
|
| Sulfonamides | 1 | 2000 | 258 | 0.010 |
Why?
|
| DNA Primers | 1 | 1999 | 661 | 0.010 |
Why?
|
| Fasting | 1 | 2000 | 296 | 0.010 |
Why?
|
| Cause of Death | 1 | 2000 | 458 | 0.010 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2000 | 304 | 0.010 |
Why?
|
| Myocardial Ischemia | 1 | 2000 | 331 | 0.010 |
Why?
|
| Triglycerides | 1 | 2000 | 561 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2007 | 4263 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2000 | 554 | 0.010 |
Why?
|
| Hematemesis | 1 | 1996 | 6 | 0.010 |
Why?
|
| Macrophages | 1 | 2000 | 607 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 1999 | 1294 | 0.010 |
Why?
|
| Parvovirus | 1 | 1996 | 8 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2000 | 1390 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2000 | 924 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2005 | 4705 | 0.010 |
Why?
|
| Adenoviruses, Human | 1 | 1996 | 80 | 0.010 |
Why?
|
| Simplexvirus | 1 | 1996 | 99 | 0.010 |
Why?
|
| Homeostasis | 1 | 2000 | 681 | 0.010 |
Why?
|
| Anemia, Hemolytic | 1 | 1995 | 30 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 2000 | 766 | 0.010 |
Why?
|
| Insulin | 1 | 2000 | 1197 | 0.010 |
Why?
|
| Survival Analysis | 1 | 1998 | 1470 | 0.010 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 1994 | 60 | 0.010 |
Why?
|
| Cytomegalovirus | 1 | 1996 | 268 | 0.010 |
Why?
|
| Molecular Probes | 1 | 1994 | 30 | 0.010 |
Why?
|
| RNA, Viral | 1 | 1997 | 540 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 1998 | 1313 | 0.010 |
Why?
|
| Serologic Tests | 1 | 1994 | 119 | 0.010 |
Why?
|
| Arteries | 1 | 1995 | 222 | 0.010 |
Why?
|
| Swine, Miniature | 1 | 1993 | 46 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1993 | 258 | 0.010 |
Why?
|
| Bundle of His | 1 | 1992 | 7 | 0.010 |
Why?
|
| Herpesvirus 4, Human | 1 | 1996 | 659 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2000 | 1524 | 0.010 |
Why?
|
| Tissue Donors | 1 | 1996 | 496 | 0.010 |
Why?
|
| Hemofiltration | 1 | 1992 | 13 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1994 | 317 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 1997 | 1695 | 0.010 |
Why?
|
| Pacemaker, Artificial | 1 | 1992 | 170 | 0.010 |
Why?
|
| Swine | 1 | 1993 | 1155 | 0.010 |
Why?
|
| False Negative Reactions | 1 | 1989 | 90 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 1989 | 247 | 0.010 |
Why?
|
| Stainless Steel | 1 | 1988 | 6 | 0.000 |
Why?
|
| Aged | 2 | 2000 | 19035 | 0.000 |
Why?
|
| Constriction, Pathologic | 1 | 1988 | 238 | 0.000 |
Why?
|
| Prostheses and Implants | 1 | 1988 | 151 | 0.000 |
Why?
|
| Forecasting | 1 | 1987 | 355 | 0.000 |
Why?
|
| Pediatrics | 1 | 1992 | 1139 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1989 | 6359 | 0.000 |
Why?
|
| Middle Aged | 1 | 1989 | 25931 | 0.000 |
Why?
|